Malaysia

[UPDATED] Ismail Sabri launches National Vaccine Development Roadmap, jab institute

Prime minister says move aims to boost acceptance among Malaysians to receive inoculations

Updated 2 years ago · Published on 01 Nov 2021 3:00PM

[UPDATED] Ismail Sabri launches National Vaccine Development Roadmap, jab institute
Prime Minister Datuk Seri Ismail Sabri Yaakob (centre) with Health Minister Khairy Jamaluddin (far right) and Science, Technology and Innovation Minister Datuk Seri Dr Adham Baba (second from left) at the launch of the National Vaccine Development Roadmap and Malaysian Genome and Vaccine Institute in Bangi earlier today. – Bernama pic, November 1, 2021

BANGI – Datuk Seri Ismail Sabri Yaakob today launched the National Vaccine Development Roadmap (NVDR) and Malaysian Genome and Vaccine Institute (MGVI) in an effort to turn the country into a hub for vaccine production and boost confidence in vaccine use.

The prime minister said that through NVDR and MGVI, Malaysia can produce its own vaccines that are quality, effective and safe in accordance with conditions set by the National Pharmaceutical Regulatory Agency (NPRA).

“Although R&D and vaccine production require heavy investment, such efforts have the potential to bring long-term returns for Keluarga Malaysia in the form of cost savings in treating diseases and investments by multinational companies in Malaysia.

“Through the implementation of the NDVR and the establishment of the MGVI, high-skill human capital in various fields of research, especially those related to healthcare and vaccines, can be produced,” he said at the launch ceremony at the Malaysian Genome Institute here.

Also present were Science, Technology and Innovation Minister Datuk Seri Dr Adham Baba and Health Minister Khairy Jamaluddin.

“More job opportunities can be created for Keluarga Malaysia to help increase the number of skilled workers and enhance the standard of living and health of the people,” he added.

Ismail Sabri said NVDR will not focus solely on Covid-19, instead its role will cover the development of vaccines for other diseases, including head and neck cancer by Cancer Research Centre.

He said three projects are ready to be implemented through NVDR, with the first involving the production of two types of Covid-19 jabs, using the inactivated virus and mRNA, developed by the Institute for Medical Research.

He said for this purpose, the funds extended by the government involve research allocations for the Health Ministry and Sukuk Prihatin totalling RM3.5 million.

The second project – Development of Mucosal/Oral/Subunit Vaccines Against Cholera, Tuberculosis and Covid-19 – is a cholera vaccine developed in collaboration with Universiti Sains Malaysia and AIMST University, with additional funding of RM10.5 million from the Science, Technology and Innovation Ministry (Mosti) via the Strategic Research Fund, he said.

“The third project is the Pre-clinical Evaluation of a Therapeutic Cancer Vaccine for the Treatment of Head and Neck Cancer by Cancer Research Malaysia (CRM) at a cost of RM3 million, financed by Mosti.

“However, as there is not yet a facility to conduct the first human clinical trial in Malaysia, CRM will conduct the clinical trial from February 2022 until March 2023 in the United Kingdom,” he said.

On MGVI, he said upgrading MGI is in line with the institute’s scope of focusing on genome research and molecular biology in vaccine production efforts.

“I am confident that the establishment of MGVI can have a positive impact on the country from economic, social and technological aspects, thus contributing to economic stability because there is no dependence on external sources of supply,” he said.

Ismail Sabri said the government is committed to propelling research and development to produce new technologies by ensuring that 50% of the government’s research funds are provided for experimental development (pre-commercialisation activities), especially for innovations with high commercialisation potential.

Through various programmes implemented by the government, he said, the country expects more vaccine scientists to be produced, thus supporting the government’s plan to increase the ability to develop human-specific vaccines not only for domestic use but also for the global market.

He also expressed confidence that Malaysia can reduce its dependence on vaccine-producing countries as it strengthens its health security. – Bernama, November 1, 2021

Related News

Malaysia / 1w

Unity Govt cowardly, irresponsible for snuffing out GEG, bowing to pressure: Khairy

Malaysia / 2mth

Virologist urges govt to provide access to new dengue vaccine

Malaysia / 3mth

Court frees blogger of offensive video charge

Malaysia / 4mth

Tough times ahead for Anwar under Johor sultan as next king: TMJ

Malaysia / 5mth

Food delivery rider: Khairy’s newest gig?

Malaysia / 6mth

Is that it, Khairy mocks Kit Siang’s seemingly muted response to Zahid’s DNAA

Spotlight

Events

UK alumni lauded for stellar achievements as British Council observes 75 years in Malaysia

Malaysia

Don’t let politicians, activists stir up hatred against KK Mart, PBK tells cops

By The Vibes Team

Malaysia

7.7 mil people registered in Padu, 2.5 mil cyberattacks, but not one success: Rafizi

By Stephen Then

Malaysia

Farewell Aunty Bersih, you will be missed

By Ian McIntyre

Malaysia

Couple make two trips to workshop to find trapped kitten in car

Malaysia

KK Mart founder, director charged with wounding religious feelings of others over 'Allah' socks

By The Vibes Team

You may be interested

Malaysia

Petrol bomb incident an irresponsible act of violence, says DAP youth

By The Vibes Team

Malaysia

Speed limit at George Town World Heritage Site reduced to 40 km/h

By Shahrim Tamrin

Malaysia

Sabah orders immediate water supply to over 50,000 households

By Jason Santos

Malaysia

Nuzul Al-Quran: PM calls on Muslims to analyse, interpret the Quran

Malaysia

Penang’s iconic Komtar set to undergo major make-over

By Ian McIntyre

Malaysia

Unfair for government to deny rakyat subsidies based on Padu registration, says SUPP youth

By Stephen Then

Malaysia

Muhyiddin files for leave to review Court of Appeal ruling reinstating power abuse charges

Malaysia

Review of taxation structure, SARA among focus of parliament today